Paper28697342
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Wang Q and 33 others. Cancer Cell, 2017. Cited by 1,472 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Papers, record 28697342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28697342
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Neoplastic | Major topic |
| Glioblastoma | Major topic |
| Tumor Microenvironment | Major topic |
| Gene Expression Profiling | |
| Humans | |
| Phenotype | |
| Recurrence | |
| Survival Analysis | |
| T-Lymphocytes |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA120813 | NCI NIH HHS | United States | R01CA120813 | PubMed and NIH | NIH RePORTER |
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| R01 CA190121 | NCI NIH HHS | United States | R01CA190121 | PubMed and NIH | NIH RePORTER |
| P30 CA034196 | NCI NIH HHS | United States | P30CA034196 | PubMed and NIH | NIH RePORTER |
| K99 CA194289 | NCI NIH HHS | United States | K99CA194289 | PubMed and NIH | NIH RePORTER |
| R00 CA194289 | NCI NIH HHS | United States | K99CA194289 | PubMed and NIH | NIH RePORTER |
| P50 CA097257 | NCI NIH HHS | United States | P50CA097257 | PubMed and NIH | NIH RePORTER |
| P50 CA127001 | NCI NIH HHS | United States | P50CA127001 | PubMed and NIH | NIH RePORTER |
| R00CA194289 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 29,316,430 | Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. | https://conductscience.org/library/papers/29316430 |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,031,383 | GlioVis data portal for visualization and analysis of brain tumor expression datasets. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/28031383 | PubMed |
| 2 | 17,288,599 | Improved precision and accuracy for microarrays using updated probe set definitions. | BMC Bioinformatics | 2007 | https://conductscience.org/library/papers/17288599 | PubMed |
| 3 | 19,193,730 | A single-sample method for normalizing and combining full-resolution copy numbers from multiple platforms, labs and analysis methods. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19193730 | PubMed |
| 4 | 23,558,169 | An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. | Science | 2013 | https://conductscience.org/library/papers/23558169 | PubMed |
| 5 | 12,066,192 | Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). | Oncol Rep | 2002 | https://conductscience.org/library/papers/12066192 | PubMed |
| 6 | 23,079,654 | Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. | Cancer Cell | 2012 | https://conductscience.org/library/papers/23079654 | PubMed |
| 7 | 25,858,805 | Macrophages and therapeutic resistance in cancer. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858805 | PubMed |
| 8 | 21,135,147 | Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21135147 | PubMed |
| 9 | 19,427,294 | Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. | Cell Stem Cell | 2009 | https://conductscience.org/library/papers/19427294 | PubMed |
| 10 | 25,691,693 | Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas. | Neuro Oncol | 2015 | https://conductscience.org/library/papers/25691693 | PubMed |
| 11 | 25,114,226 | MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25114226 | PubMed |
| 12 | 26,973,881 | Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. | JCI Insight | 2016 | https://conductscience.org/library/papers/26973881 | PubMed |
| 13 | 16,618,716 | A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. | Cancer Res | 2006 | https://conductscience.org/library/papers/16618716 | PubMed |
| 14 | 24,113,773 | Inferring tumour purity and stromal and immune cell admixture from expression data. | Nat Commun | 2013 | https://conductscience.org/library/papers/24113773 | PubMed |
| 15 | 24,695,405 | PRADA: pipeline for RNA sequencing data analysis. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24695405 | PubMed |
| 16 | 24,457,416 | Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/24457416 | PubMed |
| 17 | 22,290,264 | Studying a complex tumor: potential and pitfalls. | Cancer J | 2012 | https://conductscience.org/library/papers/22290264 | PubMed |
| 18 | 27,001,570 | Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27001570 | PubMed |
| 19 | 24,925,914 | Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. | Science | 2014 | https://conductscience.org/library/papers/24925914 | PubMed |
| 20 | 16,530,701 | Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16530701 | PubMed |
Cited by1,237
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,472 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,989,284 | IFN-γ signaling drives multiple immunosuppressive pathways and poor clinical outcome in glioblastoma. | BMC Med | 2026 | https://conductscience.org/library/papers/42989284 | PubMed |
| 42,983,003 | Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42983003 | PubMed |
| 42,978,985 | Lactylation in glioblastoma: mechanisms and therapeutic perspectives. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42978985 | PubMed |
| 42,948,477 | Dynamics of IDH1 Mutation and Protein Expression Between Primary and Recurrent Gliomas and Their Prognostic Significance. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42948477 | PubMed |
| 42,940,022 | Cross-Cancer Characterization of CAMK2A Reveals Its Favorable Prognostic Association and Neuronal Signature Enrichment in Glioma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940022 | PubMed |
| 42,936,333 | Spatial heterogeneity in glioblastoma: linking single-cell and spatial multi-omics to vaccine immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42936333 | PubMed |
| 42,930,194 | Nuclear Eccentricity as a Potential Biomarker for Tumor Biology and Survival in Glioblastoma. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930194 | PubMed |
| 42,922,526 | Ex vivo glioblastoma migration phenotypes define clinical recurrence and tumor heterogeneity. | bioRxiv | 2026 | https://conductscience.org/library/papers/42922526 | PubMed |
| 42,919,388 | Blood-brain barrier and blood-tumoral barrier formation in glioblastoma: endothelial cells and glioblastoma stem cells at the immune-brain crossroad. | Fluids Barriers CNS | 2026 | https://conductscience.org/library/papers/42919388 | PubMed |
| 42,911,458 | Advances in Single-Cell and Spatial Omics for Glioblastoma Precision Medicine. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42911458 | PubMed |
| 42,910,261 | Immune subtypes and survival in patients with primary glioma. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42910261 | PubMed |
| 42,891,017 | A re-visit of glioblastoma molecular subtypes utilizing the 2021 WHO classification of central nervous system tumors framework. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42891017 | PubMed |
| 42,869,880 | Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis. | Oncogenesis | 2026 | https://conductscience.org/library/papers/42869880 | PubMed |
| 42,866,269 | M2 type tumor-associated macrophage-derived CCL-18 promotes glioma cell proliferation but does not mediates glioma recurrence after radiotherapy. | iScience | 2026 | https://conductscience.org/library/papers/42866269 | PubMed |
| 42,860,508 | Low-Density Lipoprotein Receptor-Targeted Biomimetic Nanoplatform Suppresses Glioblastoma Stemness and Remodels Antitumor Immunity via Dual Metabolic Disruption. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42860508 | PubMed |
| 42,818,949 | Spatial Proteomics and Epigenomics Reveal Cell Morphology and Epigenetic Gene Regulation in Human Hippocampus. | Res Sq | 2026 | https://conductscience.org/library/papers/42818949 | PubMed |
| 42,749,405 | Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach. | J Genet Eng Biotechnol | 2026 | https://conductscience.org/library/papers/42749405 | PubMed |
| 42,742,779 | Immune-related hallmark pathway heterogeneity identifies a prognostic risk signature with independent external validation in glioblastoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42742779 | PubMed |
| 42,683,315 | The ERK MAPK pathway in mesenchymal glioblastoma: tumorigenesis, microenvironmental reprogramming, and the therapeutic promise of RAS(ON) multi-selective inhibition. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42683315 | PubMed |
| 42,661,193 | Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis. | J Transl Med | 2026 | https://conductscience.org/library/papers/42661193 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28697342
GET https://conductscience.org/api/papers/v1/28697342/authors?page=2